Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fangbiao Li

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancer Biology & Therapy|April 23, 2005
PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumorsKer Yu, Judy Lucas, Tianmin Zhu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a potent nicotinic Acid receptor agonist for the treatment of dyslipidemiaJun Qin, Ashwin Rao, Xiao Chen, et al.
Plos Biology|August 26, 2025
MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosingIzzat T Raheem, Vinay Girijavallabhan, Kerry L Fillgrove, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of DyslipidemiaAnandan Palani, Ashwin U Rao, Xiao Chen, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancer Biology & Therapy|April 23, 2005
PWT-458, a novel pegylated-17-hydroxywortmannin, inhibits phosphatidylinositol 3-kinase signaling and suppresses growth of solid tumorsKer Yu, Judy Lucas, Tianmin Zhu, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a potent nicotinic Acid receptor agonist for the treatment of dyslipidemiaJun Qin, Ashwin Rao, Xiao Chen, et al.
Plos Biology|August 26, 2025
MK-8527 is a novel inhibitor of HIV-1 reverse transcriptase translocation with potential for extended-duration dosingIzzat T Raheem, Vinay Girijavallabhan, Kerry L Fillgrove, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of DyslipidemiaAnandan Palani, Ashwin U Rao, Xiao Chen, et al.
Pageof 3